4.21
0.00 (0.00%)
0.00 (0.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eloxx Pharmaceuticals Inc | ELOX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.03 | -0.71% | 4.21 | 4.10 | 4.40 | 4.24 | 4.24 | 17:59:41 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 4.00 | 4.75 | 0.75 | 15.79% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 715 | 67,854 | $ 4.28 | $ 290,667 | 213,243 | 2.87 - 14.7434 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:47:53 | formt | 15,175 | $ 4.21 | USD |
Eloxx Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 168.41M | 40.00M | $ -47.19M | -1.45 | - | 20.50M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 1.00 | 48.70% |
Eloxx Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ELOX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.12 | 4.54 | 4.01 | 4.19 | 89,374 | 0.09 | 2.18% |
| 1 Month | 4.77 | 4.77 | 3.71 | 4.25 | 160,104 | -0.56 | -11.74% |
| 3 Months | 4.64 | 8.1614 | 3.71 | 5.98 | 247,251 | -0.43 | -9.27% |
| 6 Months | 6.40 | 8.1614 | 2.87 | 5.73 | 209,213 | -2.19 | -34.22% |
| 1 Year | 11.25 | 14.7434 | 2.87 | 6.56 | 135,721 | -7.04 | -62.58% |
| 3 Years | 10.35 | 24.60 | 2.87 | 10.06 | 119,949 | -6.14 | -59.32% |
| 5 Years | 10.35 | 24.60 | 2.87 | 10.06 | 119,949 | -6.14 | -59.32% |
Eloxx Pharmaceuticals Description
| Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel ribonucleic acid (RNA)-modulating drug candidates that are formulated to treat rare and ultra-rare premature stop codon diseases. The ELX-02, the company's lead investigational drug product candidate, is a small molecule designed to restore production of full-length functional proteins. The ELX-02, is in the early stages of clinical development for systemic administration for cystic fibrosis and cystinosis. |
